We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+3.73%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.58%
AUM
$3.08B
AUM Growth
+$6.45M
Cap. Flow
-$35.2M
Cap. Flow %
-1.14%
Top 10 Hldgs %
31.18%
Holding
283
New
16
Increased
54
Reduced
105
Closed
19

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$63.4M
2
KMX icon
CarMax
KMX
+$60.8M
3
GPT
Gramercy Property Trust
GPT
+$50.4M
4
MU icon
Micron Technology
MU
+$47.5M
5
MSFT icon
Microsoft
MSFT
+$32.8M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$72.7M
2
HCA icon
HCA Healthcare
HCA
+$55.6M
3
GLNG icon
Golar LNG
GLNG
+$37.8M
4
EQT icon
EQT Corp
EQT
+$27.5M
5
ET icon
Energy Transfer Partners
ET
+$19.8M

Sector Composition

Rank Sector Weight
1 Healthcare 21.48%
2 Industrials 20.68%
3 Technology 18.28%
4 Consumer Discretionary 10.45%
5 Financials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QDEL icon
76
QuidelOrtho
QDEL
$958M
$9.65M 0.31%
487,000
GOOGL icon
77
Alphabet (Google) Class A
GOOGL
$4.14T
$9.38M 0.3%
+240,820
New +$8.91M
PG icon
78
Procter & Gamble
PG
$340B
$9.35M 0.3%
117,522
-1,965
-2% -$150K
MDLZ icon
79
Mondelez International
MDLZ
$78.2B
$8.79M 0.29%
196,089
-9,143
-4% -$409K
INTC icon
80
Intel
INTC
$506B
$8.66M 0.28%
251,300
+1,000
+0.4% +$33.8K
MTDR icon
81
Matador Resources
MTDR
$7.32B
$8.02M 0.26%
397,725
+27,975
+8% +$683K
GILD icon
82
Gilead Sciences
GILD
$187B
$7.79M 0.25%
77,035
-450
-0.6% -$46.8K
MACK
83
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$7.75M 0.25%
133,605
ADP icon
84
Automatic Data Processing
ADP
$110B
$7.42M 0.24%
87,632
HON icon
85
Honeywell
HON
$66.4B
$7M 0.23%
74,990
-888
-1% -$81.4K
RDS.A
86
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$6.57M 0.21%
150,995
-3,205
-2% -$153K
BIP icon
87
Brookfield Infrastructure Partners
BIP
$17.1B
$6.48M 0.21%
430,681
-56,574
-12% -$901K
CSCO icon
88
Cisco
CSCO
$431B
$6.26M 0.2%
230,375
+200
+0.1% +$5.52K
TMO icon
89
Thermo Fisher Scientific
TMO
$227B
$5.89M 0.19%
41,550
TRAK icon
90
ReposiTrak
TRAK
$144M
$5.8M 0.19%
515,432
MFA
91
MFA Financial
MFA
$905M
$5.67M 0.18%
214,863
-222,700
-51% -$6.15M
ITW icon
92
Illinois Tool Works
ITW
$76.9B
$5.56M 0.18%
59,978
+98
+0.2% +$8.9K
DISCK
93
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$5.53M 0.18%
219,336
-2,854
-1% -$78K
TGT icon
94
Target
TGT
$74.7B
$5.45M 0.18%
75,025
-56,830
-43% -$4.24M
AFL icon
95
Aflac
AFL
$58.8B
$5.33M 0.17%
177,940
RTX icon
96
RTX Corp
RTX
$271B
$5.31M 0.17%
87,899
-16,236
-16% -$982K
MMM icon
97
3M
MMM
$86.9B
$5.3M 0.17%
42,076
+4,544
+12% +$584K
WELL icon
98
Welltower
WELL
$170B
$5.24M 0.17%
77,045
-66,940
-46% -$4.37M
DVA icon
99
DaVita
DVA
$11.7B
$5M 0.16%
71,700
-6,000
-8% -$440K
XNCR icon
100
Xencor
XNCR
$1.98B
$4.94M 0.16%
347,650
+6,700
+2% +$90.1K

Similar funds

Cannell & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Cannell & Co held 283 positions worth $3.08B, up 0.21% from $3.08B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Cannell & Co's Q4 2015 filing shows 16 new, 54 increased, 105 reduced and 19 closed positions. Its largest new stake was Micron Technology: 2,969,275 shares worth $42.2M. The largest sale was Goldman Sachs, an estimated $72.7M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

  • Cannell & Co's largest Q4 2015 buy was Micron Technology: 2,969,275 shares worth $42.2M.
  • Cannell & Co added most to Apple in Q4 2015, an estimated $63.4M increase.
  • Cannell & Co's biggest Q4 2015 reduction was Goldman Sachs, cutting an estimated $72.7M.
  • Cannell & Co fully exited Golar LNG in Q4 2015, selling an estimated $37.8M.
  • Cannell & Co's ten largest holdings make up 31% of its $3.08B portfolio in Q4 2015.
  • Cannell & Co opened 16 new positions and closed 19 in Q4 2015.
  • Cannell & Co's portfolio value rose 0.21% quarter-over-quarter to $3.08B.

Based on Cannell & Co's 13F filing for Q4 2015, filed 11 Feb 2016.